Bristol-Myers Squibb (BMY) Reports In-Line Q2 EPS, Updates FY EPS Guidance
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $55.55 +1.55%
EPS Growth %: +10.3%
Financial Fact:
Research and development: 1.14B
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +10.3%
Financial Fact:
Research and development: 1.14B
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $0.74, in-line with the analyst estimate of $0.74. Revenue for the quarter came in at $5.14 billion versus the consensus estimate of $5.09 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2017 EPS of $2.90-$3.00, versus the consensus of $2.95.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Jabil (JBL) Tops Q3 EPS by 8c, Offers Guidance
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
